MARKET

OCEAW

OCEAW

Ocean Biomedical Inc.
NASDAQ
0.0190
-0.0009
-4.52%
Closed 15:23 04/17 EDT
OPEN
0.0161
PREV CLOSE
0.0199
HIGH
0.0345
LOW
0.0153
VOLUME
28.18K
TURNOVER
--
52 WEEK HIGH
0.1820
52 WEEK LOW
0.0150
MARKET CAP
--
P/E (TTM)
-0.0551
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OCEAW last week (0407-0411)?
Weekly Report · 6d ago
Weekly Report: what happened at OCEAW last week (0331-0404)?
Weekly Report · 04/07 11:44
Weekly Report: what happened at OCEAW last week (0324-0328)?
Weekly Report · 03/31 11:58
OCEAN BIOMEDICAL ANNOUNCES GRANT ON PATENT RIGHT FOR BISPECIFIC ANTIBODIES TARGETING CHI3L1 AND PD1 FOR ENHANCED TUMOR CELL CYTOTOXICITY IN CHINA
Reuters · 03/28 12:30
Weekly Report: what happened at OCEAW last week (0317-0321)?
Weekly Report · 03/24 11:44
Weekly Report: what happened at OCEAW last week (0310-0314)?
Weekly Report · 03/17 11:56
Weekly Report: what happened at OCEAW last week (0303-0307)?
Weekly Report · 03/10 11:59
Weekly Report: what happened at OCEAW last week (0224-0228)?
Weekly Report · 03/03 11:58
More
About OCEAW
Ocean Biomedical, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The Company helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). It offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.

Webull offers Ocean Biomedical Inc stock information, including NASDAQ: OCEAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCEAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCEAW stock methods without spending real money on the virtual paper trading platform.